Similar Articles |
|
Nursing Management January 2012 Lawrence et al. |
Type 2 Diabetes: Growing to Epic Proportions Affecting all age groups and all aspects of a person's life, diabetes is a major public health issue worldwide, requiring lifelong behavioral and lifestyle changes and support. |
Managed Care May 2006 Fadia T. Shaya & Deshpande |
New Treatment Approaches To Diabetes The goal of diabetes management is maintaining glycemic control while targeting quality of life improvements. |
Pharmaceutical Executive August 1, 2011 Jennifer Ringler |
The Adherence Fight: A TKO? Why does the match against medicines compliance always seem to end in an easy knockout? |
Pharmaceutical Executive June 1, 2014 Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
Nursing January 2011 Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
Managed Care October 2004 Martin Sipkoff |
Not So Much of a Reach: Let Sick Pay Less for Drugs The idea is radical and simple: Those who need medication the most should pay the least. There is evidence that this is cost-effective. |
Managed Care May 2006 Martin Sipkoff |
Health Plans Are Ill-Prepared for Looming Diabetes Epidemic The problem is outpacing insurers' resources and perhaps even their commitment. Can the chronic care model help? |
American Family Physician May 1, 2001 Beatriz Luna & Mark N. Feinglos |
Oral Agents in the Management of Type 2 Diabetes Mellitus Currently, there are five distinct classes of hypoglycemic agents available, each class displaying unique pharmacologic properties... |
Pharmaceutical Executive August 1, 2008 George Koroneos |
Hard of (Ad)hering Companies have responded to declining profits with a proliferation of patient compliance programs. But where is pharma in this paradigm shift? |
Pharmaceutical Executive February 1, 2011 Jennifer Ringler |
Skipping the Needle: Pharm Exec's Brand of the Year Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story |
Nurse Practitioner October 2010 Hill & Appel |
Diagnosing Diabetes with A1C: Implications and Considerations for Measurement and Surrogate Markers Now that the ADA has officially positioned the assay as a means of diagnosis and monitoring, it is another tool NPs must access properly when helping patients manage diabetes and treatment. |
Pharmaceutical Executive December 1, 2011 William Looney |
The Medicines Adherence Challenge Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma, but is it? An expert round table examines how best to make progress and agree on some practical steps for incorporation in the campaign agenda. |
American Family Physician October 15, 2003 Gavin et al. |
Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels. |
Nurse Practitioner May 2011 Stacey A. Seggelke |
Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes. |
Managed Care October 2007 Martin Sipkoff |
Asheville's Legacy: Pharmacy Moves From Dispensing to Clinical Management It is an idea whose time has finally come: Today's clinical pharmacists are involved in virtually all aspects of medical care. |
American Family Physician October 15, 2005 Coleman & Newton |
Supporting Self-Management in Patients with Chronic Illness Family physicians can support patient self-management by structuring patient-physician interactions to identify problems from the patient perspective, making office environment changes that remove self-management barriers, and providing education individually and through available community self-management resources. |
The Motley Fool June 28, 2010 Luke Timmerman |
Orexigen Drug Shows Potential as "Two-Fer" Against Obesity and Diabetes Orexigen's latest drug aims at treating both diabetes and obesity. |
American Journal of Nursing October 2005 Charlotte Thomas-Hawkins |
Self-Management of Chronic Kidney Disease Effective management of this disease requires the patient to be the principal illness manager and this skill requires the nurses guidance and support. |
Pharmaceutical Executive March 1, 2013 Ben Comer |
Brand of the Year: Januvia When Merck's Januvia received its first regulatory approval, in Mexico in 2006, no one predicted its long-term success. In 2012, the company's diabetes franchise became the highest-selling product family in Merck's 122-year history. |
Pharmaceutical Executive August 1, 2008 Gayle Lorenzi et al. |
Spanning the Treatment Gap How a diabetes field team helped docs overcome the treatment gap. |
Managed Care June 2003 Alison Johnson |
Measuring DM's Net Effect Is Harder Than You Might Think Disease management is God's gift to managed care. Or is it? Here is a discussion of areas that make evaluating a DM program a complex, if not ineffable, proposition. |
BusinessWeek October 22, 2009 Arlene Weintraub |
Tough Love, Lower Health Costs A UnitedHealthcare plan offers incentives to employees who strictly control their diabetes. |
Nurse Practitioner March 2012 Baumann & Dang |
Helping Patients with Chronic Conditions Overcome Barriers to Self-Care Here are approaches nurse practitioners can use to reduce or eliminate barriers to self-care in adults with chronic conditions. |
Managed Care August 2004 Alan Lotvin |
Specialty Pharmacy Presents Unique Set of Challenges Only a small percent of a typical health plan's population takes medicine for conditions outside the generalist's scope. But it's a big portion of the drug bill. |
American Family Physician January 15, 2004 Koenigsberg et al. |
Facilitating Treatment Adherence with Lifestyle Changes in Diabetes Healthy eating and increased physical activity can prevent or delay diabetes and its complications. Techniques that facilitate adherence to these lifestyle changes can be adapted to primary care. |
American Family Physician September 15, 2006 Havas & Donner |
Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications. |
Managed Care May 2003 Wayne Miller |
Higher Drug Copays Now Might Cause Problems Later The long-term impact of noncompliance must be considered before copayments are increased. This is especially true where chronic conditions are concerned. |
Nursing September 2010 Margaret M. Bolton |
Sounding the alarm about metabolic syndrome Any health problem that affects a third of American adults is sure to impact your nursing practice. Metabolic syndrome, a growing and commonly silent condition, poses a significant public health crisis. |
Managed Care July 2007 Martin Sipkoff |
Lowering Copayments Can Improve Quality of Chronic Disease Care Employers and health plans are starting to see the advantage of what has been termed evidence-based benefit design. |
American Family Physician January 15, 2007 Pollock et al. |
Appropriate Prescribing of Medications: An Eight-Step Approach These eight steps, along with ongoing self-directed learning, compose a systematic approach to prescribing that is efficient and practical for the family physician. |
Nursing May 2010 Debra Castner |
Understanding the stages of chronic kidney disease This article will help you to recognize CKD and understand its stages so you can help your patient to modify risk factors, prevent further kidney damage, and manage complications. First, consider the scope of the problem. |
Nurse Practitioner July 2010 Kristine A. Scordo |
Treating antiretroviral-induced dyslipidemia in HIV-infected adults Studies indicate that HIV-infected patients (both males and females) may be at an increased risk for the development of cardiovascular disease |
Nurse Practitioner December 2011 |
Managing pain in obese patients Obesity-related pain conditions can limit the patient's efforts at increasing activity and limit quality of life. This article will offer information on these conditions and treatment options. |
American Family Physician October 1, 2002 Konzem et al. |
Controlling Hypertension in Patients with Diabetes Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications. |
American Journal of Nursing July 2010 Ruppar & Conn |
Interventions to Promote Physical Activity in Chronically Ill Adults The health benefits of physical activity in chronic illness are well documented. |
American Family Physician September 1, 2006 Gardiner & Dvorkin |
Promoting Medication Adherence in Children The problem of getting children to follow a treatment regimen is widespread and is frustrating for physicians. Having the child participate in devising the plan improves adherence. |
Managed Care February 2001 T. Jeffrey White |
Making Pharmacoeconomics In Formulary Development a Reality Despite what might be commonly believed, pharmacoeconomics is not a widely used tool for formulary development. Here's a model to follow... |
American Family Physician December 15, 2000 Alan J. Garber |
Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes All cardiovascular risk factors except smoking are more prevalent in patients with type 2 diabetes. In addition to exercise, weight control, aspirin therapy and blood pressure control, therapy to modify lipid profiles is usually necessary... |
Managed Care February 2004 |
Improving Oral Pharmacologic Treatment And Management of Type 2 Diabetes New oral treatment options and outcome measures may help patients with type 2 diabetes to achieve better results while reducing associated costs. |
Managed Care August 2004 Martin Sipkoff |
Bad Tiered Formulary Designs Yield Poor Outcomes, High Cost Now that tiered formularies rule the land, what many suspected is being demonstrated: Compliance is suffering and so, too, are patients. |
Nurse Practitioner February 2012 Jennifer M. Belavic |
Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice |
American Family Physician November 1, 2003 Turok et al. |
Management of Gestational Diabetes Mellitus Although the disorder affects approximately 2.5 percent of pregnant women and has been the subject of extensive research, its diagnosis and management continue to be debated. |
IEEE Spectrum October 2011 Joseph M. Smith |
Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon |
Managed Care February 2001 Christopher M. Dezii |
Persistence With Drug Therapy A practical approach using administrative claims data... |
Pharmaceutical Executive November 1, 2012 Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Nurse Practitioner February 2011 Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
Managed Care March 2001 |
A Comparison of Diabetes Patients' Self-Reported Health Status With Hemoglobin A1c Test Results There were substantive differences noted between diabetes patients' self-reported health status, their level of satisfaction with the care they received, and the actual care they received... |
Pharmaceutical Executive September 1, 2011 Richard Gliklich |
The Power of Observation Observational studies present a compelling real-world corollary to the classic randomized clinical trial. |
Nursing November 2009 Christine Kessler |
Glycemic control in the hospital: How tight should it be? Based on recent studies, the answer to that question remains controversial. This article will explore this issue and present current best practices for caring for a patient in the hospital who has diabetes or hyperglycemia. |
Nursing Management March 2012 Yvonne D'Arcy |
Pain and obesity It can be a challenge to provide effective pain management for obese patients; however, a multimodal pain management regimen that combines medications and complementary techniques can help increase pain relief. |